Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy, Prostatic Neoplasms”

2,726 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,726 results

Not applicableUnknownNCT04656678
What this trial is testing

Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CancerProstate Disease
Northwell Health 200
Large-scale testing (Phase 3)Study completedNCT01819285
What this trial is testing

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

Who this might be right for
Neoplasm, Prostate
European Organisation for Research and Treatment of Cancer - EORTC 985
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430192
What this trial is testing

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy

Who this might be right for
Prostatic Neoplasms
Peter MacCallum Cancer Centre, Australia 20
Not applicableLooking for participantsNCT05722392
What this trial is testing

Safety and Efficacy of Two-step Radical Prostatectomy

Who this might be right for
Prostate Cancer
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05059236
What this trial is testing

Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer
Bayer 223
Large-scale testing (Phase 3)Study completedNCT02288247
What this trial is testing

Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Europe Ltd. 688
Testing effectiveness (Phase 2)Study completedNCT00257478
What this trial is testing

The Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

Who this might be right for
Prostate CancerCancer of ProstateProstatic Cancer+1 more
Astellas Pharma Inc
Testing effectiveness (Phase 2)UnknownNCT04736108
What this trial is testing

Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate

Who this might be right for
Prostate Cancer
West China Hospital 50
Not applicableUnknownNCT06387238
What this trial is testing

Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Peking University First Hospital 150
Testing effectiveness (Phase 2)Ended earlyNCT01816048
What this trial is testing

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

Who this might be right for
Prostatic NeoplasmsProstate Cancer
University of Wisconsin, Madison 8
Not applicableLooking for participantsNCT06238713
What this trial is testing

Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)

Who this might be right for
Prostate AdenocarcinomaLocalized Prostate Carcinoma
Shanghai Changzheng Hospital 480
Not applicableStudy completedNCT06773858
What this trial is testing

Genetic Studies of Prostate Cancer Aggressiveness and Prognosis

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer After a Radical Treatment
Karolinska Institutet 2,291
Testing effectiveness (Phase 2)Study completedNCT01751438
What this trial is testing

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT02716974
What this trial is testing

Definitive Therapy to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Post-approval studies (Phase 4)Study completedNCT00280098
What this trial is testing

Docetaxel in the Treatment of Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Sanofi 30
Testing effectiveness (Phase 2)Study completedNCT02182063
What this trial is testing

A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Boehringer Ingelheim 81
Not applicableWithdrawnNCT00161252
What this trial is testing

Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly

Who this might be right for
Prostate Cancer
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)WithdrawnNCT05807126
What this trial is testing

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00241384
What this trial is testing

Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer

Who this might be right for
Prostate Cancer
Schiffler Cancer Center 396
Not applicableStudy completedNCT01856855
What this trial is testing

Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)

Who this might be right for
Prostate CancerProstate AdenocarcinomaRadiation Toxicity+1 more
John Fiveash, MD 26
Load More Results